Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association

Circulation. 2013 Oct 22;128(17):1927-95. doi: 10.1161/CIR.0b013e3182a88099. Epub 2013 Sep 30.

Authors

Steven E Lipshultz, M Jacob Adams, Steven D Colan, Louis S Constine, Eugene H Herman, Daphne T Hsu, Melissa M Hudson, Leontien C Kremer, David C Landy, Tracie L Miller, Kevin C Oeffinger, David N Rosenthal, Craig A Sable, Stephen E Sallan, Gautam K Singh, Julia Steinberger, Thomas R Cochran, James D Wilkinson; American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Basic Cardiovascular Sciences, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Radiolo

PMID: 24081971
DOI: 10.1161/CIR.0b013e3182a88099

No abstract available

Keywords: AHA Scientific Statements; adolescent; antineoplastic agents; cancer; children; prevention and control; toxicity.

Publication types

Practice Guideline

MeSH terms

Adolescent
American Heart Association*
Antineoplastic Agents / adverse effects*
Cardiology / standards*
Cardiovascular Diseases / chemically induced*
Cardiovascular Diseases / physiopathology*
Cardiovascular Diseases / prevention & control
Child
Drug Monitoring / standards
Humans
Neoplasms / drug therapy*
United States
Young Adult

Substances

Antineoplastic Agents